LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 5-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL

N. Ruperto, H. I. Brunner, P. Quartier, T. Constantin, E. Alexeeva, R. Schneider, I. Kone-Paut, K. Schikler, K. Marzan, N. Wulffraat, S. Padeh, V. Chasnyk, C. Wouters, J. B. Kuemmerle-Deschner, T. Kallinich, B. Lauwerys, E. Haddad, E. Nasonov, M. Trachana, O. VougioukaK. Leon, A. Speziale, K. Lheritier, A. Martini, D. Lovell

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)265-266
JournalAnnals of the Rheumatic Diseases
Volume75
DOIs
Publication statusPublished - Jun 2016

Cite this